A Global Effort
Our Country Partners
In 2022 we partnered with 31 countries (or regions) in Africa, Asia, the Middle East, South America, and the Western Pacific to distribute Mectizan® for the elimination of onchocerciasis (also known as river blindness) and lymphatic filariasis (LF). A total of 377.8 million treatments were approved. This total included 316.1 million treatments in countries where LF and river blindness are co-endemic and 61.6 million treatments in 6 countries implementing “triple therapy,” also known as IDA (which stands for ivermectin [Mectizan], diethylcarbamazine [DEC], and albendazole).
Mectizan has been sent to 58 countries since the donation was announced in 1987.
County/Territory | Status |
---|---|
American Samoa | LF treatment ongoing |
Angola | River blindness & LF treatment ongoing |
Benin | River blindness treatment ongoing |
Brazil | River blindness treatment ongoing |
Burkina Faso | River blindness & LF treatment ongoing |
Burundi | River blindness treatment ongoing |
Cameroon | River blindness treatment ongoing |
Central African Republic | River blindness & LF treatment ongoing |
Chad | River blindness & LF treatment ongoing |
Colombia | River blindness eliminated |
Comoros | LF treatment ongoing |
Congo | River blindness & LF treatment ongoing |
Côte d'Ivoire | River blindness & LF treatment ongoing |
Democratic Republic of the Congo | River blindness & LF treatment ongoing |
Ecuador | River blindness eliminated |
Egypt | LF eliminated (Mectizan was used to clear up hotspots after Egypt was validated to be free of LF) |
Equatorial Guinea | River blindness treatment ongoing |
Eritrea | LF treatment ongoing |
Ethiopia | River blindness & LF treatment ongoing |
Fiji | LF treatment ongoing |
French Polynesia | LF treatment ongoing |
Gabon | River blindness & LF treatment not started |
Ghana | River blindness & LF treatment ongoing |
Guatemala | River blindness eliminated |
Guinea | River blindness & LF treatment ongoing |
Guinea-Bissau | River blindness & LF treatment ongoing |
Guyana | LF treatment ongoing |
Haiti | LF treatment ongoing |
India | LF treatment ongoing |
Indonesia | LF treatment ongoing |
Kenya | LF treatment ongoing |
Liberia | River blindness & LF treatment ongoing |
Madagascar | LF treatment ongoing |
Malawi | River blindness treatment ongoing; LF eliminated |
Malaysia | LF treatment ongoing |
Mali | River blindness treatment ongoing |
Mexico | River blindness eliminated |
Mozambique | LF treatment ongoing (co-endemic with river blindness) |
Myanmar | LF treatment ongoing |
Nepal | LF treatment ongoing |
New Caledonia | LF treatment ongoing |
Niger | LF treatment ongoing (co-endemic with river blindness) |
Nigeria | River blindness & LF treatment ongoing |
Papua New Guinea | LF treatment ongoing |
Philippines | LF treatment ongoing |
Samoa | LF treatment ongoing |
São Tomé and Príncipe | LF treatment ongoing |
Senegal | River blindness & LF treatment ongoing |
Sierra Leone | River blindness & LF treatment ongoing |
South Sudan | River blindness & LF treatment ongoing |
Sudan | River blindness & LF treatment ongoing |
Tanzania | River blindness & LF treatment ongoing |
Timor-Leste | LF treatment ongoing |
Togo | River blindness treatment ongoing; LF eliminated |
Tuvalu | LF treatment ongoing |
Uganda | River blindness treatment ongoing |
Venezuela | River blindness treatment ongoing |
Yemen | River blindness treatment ongoing; LF eliminated |